Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1186/s12916-023-02900-z | First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes |
| https://doi.org/10.3389/fimmu.2024.1446748 | A future of AI-driven personalized care for people with multiple sclerosis |
| https://doi.org/10.3389/fimmu.2016.00067 | Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model |
| https://doi.org/10.1186/s12916-024-03476-y | First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers |
| https://doi.org/10.1016/j.neucom.2024.128762 | Industrial and medical anomaly detection through cycle-consistent adversarial networks |
| https://doi.org/10.3389/fneur.2025.1557947 | RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis |
| https://doi.org/10.3389/fimmu.2015.00449 | MHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4+ T Cells with Apoptosis-Inducing Properties |
| https://doi.org/10.1016/j.cellimm.2015.09.007 | T cell response to FVIII |
| https://doi.org/10.1136/annrheumdis-2020-eular.2714 | THU0032 MODIFIED PEPTIDES AS A NOVEL IMMUNOTHERAPY FOR RHEUMATOID ARTHRITIS |
| https://doi.org/10.3389/fimmu.2018.01600 | Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model |
| https://doi.org/10.1089/hum.2015.039 | Suppression of Immune Response to Adenovirus Serotype 5 Vector by Immunization with Peptides Containing an MHC Class II Epitope and a Thio-Oxidoreductase Motif |
| Interlude: CT of Peruvian whistling bottles. | |
| https://doi.org/10.1016/j.jcyt.2015.03.376 | Technology transfer and process development for an autologous T cell therapy against multiple sclerosis |
| Modified peptides as a novel immunotherapy for rheumatoid arthritis |